qa_id string | split string | patient_id int64 | slice_id int64 | unique_id string | image_id int64 | question string | answer string | answer_type string | question_family string | template_id string | paraphrase_id string | dataset_branch string | question_style string | difficulty_level string | ambiguity_flag string | region_target_primary string | region_target_secondary string | signal_gap_bucket string | decision_rule_id string | label_provenance string | candidate_keep_reason string | modality_context string | tumor_slice_csv int64 | edema_area_pixels int64 | ncr_net_area_pixels int64 | enhancing_area_pixels int64 | tumor_area_pixels int64 | context_area_pixels int64 | global_area_pixels int64 | edema_uncertainty float64 | ncr_net_uncertainty float64 | enhancing_uncertainty float64 | tumor_uncertainty float64 | context_uncertainty float64 | global_uncertainty float64 | edema_weight float64 | ncr_net_weight float64 | enhancing_weight float64 | tumor_weight float64 | context_weight float64 | global_weight float64 | phase2a_token_file string | slice_index_in_token_file int64 | phase2c_file string | slice_index_in_ugtm_file int64 | mc_dropout_passes int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BTUMQA225K_24716f3aeba265 | train | 0 | 49 | 00000_049 | 49 | What is the confidence-qualified presence status of edema in this slice? | not_present | classification | confidence_qualified_presence | confidence_qualified_presence_template_01 | confidence_qualified_presence_paraphrase_01 | btumqa_225k | confidence_qualified | easy | no | edema | null | wide_gap | confidence_qualified_presence_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 0 | 4 | 0 | 0 | 4 | 378 | 13,050 | 0.045768 | 0 | 0 | 0.045768 | 0.014483 | 0.001143 | 0.954232 | 1 | 1 | 0.954232 | 0.985517 | 0.998857 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 0 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 0 | 20 |
BTUMQA225K_f7814293977158 | train | 0 | 49 | 00000_049 | 49 | What is the confidence-qualified extent of the whole tumor in this slice? | none | classification | confidence_qualified_extent | confidence_qualified_extent_template_01 | confidence_qualified_extent_paraphrase_01 | btumqa_225k | confidence_qualified | easy | no | tumor | null | wide_gap | confidence_qualified_extent_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 0 | 4 | 0 | 0 | 4 | 378 | 13,050 | 0.045768 | 0 | 0 | 0.045768 | 0.014483 | 0.001143 | 0.954232 | 1 | 1 | 0.954232 | 0.985517 | 0.998857 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 0 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 0 | 20 |
BTUMQA225K_153fc861d55689 | train | 0 | 50 | 00000_050 | 50 | How large is the uncertainty gap between enhancing tumor and the whole tumor region? | moderate_gap | classification | uncertainty_gap_bucket | uncertainty_gap_bucket_template_01 | uncertainty_gap_bucket_paraphrase_01 | btumqa_225k | bucketed | medium | no | enhancing | tumor | moderate_gap | uncertainty_gap_bucket_v1 | phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 0 | 42 | 45 | 92 | 179 | 892 | 13,409 | 0.053225 | 0.080099 | 0.060797 | 0.063873 | 0.016343 | 0.001996 | 0.946775 | 0.919901 | 0.939204 | 0.936127 | 0.983657 | 0.998004 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 1 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 1 | 20 |
BTUMQA225K_20faaba07d208b | train | 0 | 50 | 00000_050 | 50 | After accounting for reliability, which tumor subregion remains most dominant in this slice? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_01 | dominant_region_under_uncertainty_paraphrase_01 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | edema | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 0 | 42 | 45 | 92 | 179 | 892 | 13,409 | 0.053225 | 0.080099 | 0.060797 | 0.063873 | 0.016343 | 0.001996 | 0.946775 | 0.919901 | 0.939204 | 0.936127 | 0.983657 | 0.998004 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 1 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 1 | 20 |
BTUMQA225K_9d20b7d9b0308a | train | 0 | 50 | 00000_050 | 50 | Between edema and enhancing tumor, which region is more reliable for reasoning? | edema | classification | more_reliable_region | more_reliable_region_template_01 | more_reliable_region_paraphrase_01 | btumqa_225k | comparative | medium | no | edema | enhancing | moderate_gap | more_reliable_region_v1 | phase2c_weight | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 0 | 42 | 45 | 92 | 179 | 892 | 13,409 | 0.053225 | 0.080099 | 0.060797 | 0.063873 | 0.016343 | 0.001996 | 0.946775 | 0.919901 | 0.939204 | 0.936127 | 0.983657 | 0.998004 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 1 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 1 | 20 |
BTUMQA225K_ad3a6be227473a | train | 0 | 50 | 00000_050 | 50 | Between edema and enhancing tumor, where is the uncertainty higher? | enhancing | classification | more_uncertain_region | more_uncertain_region_template_03 | more_uncertain_region_paraphrase_03 | btumqa_225k | comparative | medium | no | edema | enhancing | moderate_gap | more_uncertain_region_v1 | phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 0 | 42 | 45 | 92 | 179 | 892 | 13,409 | 0.053225 | 0.080099 | 0.060797 | 0.063873 | 0.016343 | 0.001996 | 0.946775 | 0.919901 | 0.939204 | 0.936127 | 0.983657 | 0.998004 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 1 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 1 | 20 |
BTUMQA225K_c4c45b1d3165f7 | train | 0 | 50 | 00000_050 | 50 | How large is the reliability gap between enhancing tumor and the whole tumor region? | moderate_gap | classification | reliability_gap_bucket | reliability_gap_bucket_template_01 | reliability_gap_bucket_paraphrase_01 | btumqa_225k | bucketed | medium | no | enhancing | tumor | moderate_gap | reliability_gap_bucket_v1 | phase2c_weight | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 0 | 42 | 45 | 92 | 179 | 892 | 13,409 | 0.053225 | 0.080099 | 0.060797 | 0.063873 | 0.016343 | 0.001996 | 0.946775 | 0.919901 | 0.939204 | 0.936127 | 0.983657 | 0.998004 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 1 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 1 | 20 |
BTUMQA225K_cfba1c148f3b42 | train | 0 | 50 | 00000_050 | 50 | Are edema and necrotic or non-enhancing tumor core too close to separate confidently here? | distinct | classification | ambiguous_subregion_pair | ambiguous_subregion_pair_template_02 | ambiguous_subregion_pair_paraphrase_02 | btumqa_225k | ambiguity_sensitive | easy | no | edema | ncr_net | wide_gap | ambiguous_subregion_pair_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 0 | 42 | 45 | 92 | 179 | 892 | 13,409 | 0.053225 | 0.080099 | 0.060797 | 0.063873 | 0.016343 | 0.001996 | 0.946775 | 0.919901 | 0.939204 | 0.936127 | 0.983657 | 0.998004 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 1 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 1 | 20 |
BTUMQA225K_0191f290e4cad2 | train | 0 | 51 | 00000_051 | 51 | Between enhancing tumor and the whole tumor region, where is the uncertainty higher? | tumor | classification | more_uncertain_region | more_uncertain_region_template_03 | more_uncertain_region_paraphrase_03 | btumqa_225k | comparative | easy | no | enhancing | tumor | wide_gap | more_uncertain_region_v1 | phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 0 | 55 | 74 | 263 | 392 | 1,056 | 13,699 | 0.042999 | 0.073363 | 0.028725 | 0.039154 | 0.009119 | 0.001858 | 0.957001 | 0.926637 | 0.971275 | 0.960846 | 0.990881 | 0.998142 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 2 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 2 | 20 |
BTUMQA225K_598044a81b1c08 | train | 0 | 51 | 00000_051 | 51 | Between enhancing tumor and the whole tumor region, which token is more reliable? | enhancing | classification | more_reliable_region | more_reliable_region_template_03 | more_reliable_region_paraphrase_03 | btumqa_225k | comparative | easy | no | enhancing | tumor | wide_gap | more_reliable_region_v1 | phase2c_weight | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 0 | 55 | 74 | 263 | 392 | 1,056 | 13,699 | 0.042999 | 0.073363 | 0.028725 | 0.039154 | 0.009119 | 0.001858 | 0.957001 | 0.926637 | 0.971275 | 0.960846 | 0.990881 | 0.998142 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 2 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 2 | 20 |
BTUMQA225K_817d460816e5f3 | train | 0 | 51 | 00000_051 | 51 | Which tumor subregion is strongest after uncertainty-aware adjustment? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_02 | dominant_region_under_uncertainty_paraphrase_02 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | edema | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 0 | 55 | 74 | 263 | 392 | 1,056 | 13,699 | 0.042999 | 0.073363 | 0.028725 | 0.039154 | 0.009119 | 0.001858 | 0.957001 | 0.926637 | 0.971275 | 0.960846 | 0.990881 | 0.998142 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 2 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 2 | 20 |
BTUMQA225K_d958aa40f2a509 | train | 0 | 51 | 00000_051 | 51 | Is the uncertainty difference between edema and the whole tumor region close, moderate, or wide? | moderate_gap | classification | uncertainty_gap_bucket | uncertainty_gap_bucket_template_02 | uncertainty_gap_bucket_paraphrase_02 | btumqa_225k | bucketed | medium | no | edema | tumor | moderate_gap | uncertainty_gap_bucket_v1 | phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 0 | 55 | 74 | 263 | 392 | 1,056 | 13,699 | 0.042999 | 0.073363 | 0.028725 | 0.039154 | 0.009119 | 0.001858 | 0.957001 | 0.926637 | 0.971275 | 0.960846 | 0.990881 | 0.998142 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 2 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 2 | 20 |
BTUMQA225K_de9133a92f3f0f | train | 0 | 51 | 00000_051 | 51 | Does this slice show an ambiguity-sensitive competition between edema and necrotic or non-enhancing tumor core? | distinct | classification | ambiguous_subregion_pair | ambiguous_subregion_pair_template_03 | ambiguous_subregion_pair_paraphrase_03 | btumqa_225k | ambiguity_sensitive | medium | no | edema | ncr_net | moderate_gap | ambiguous_subregion_pair_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 0 | 55 | 74 | 263 | 392 | 1,056 | 13,699 | 0.042999 | 0.073363 | 0.028725 | 0.039154 | 0.009119 | 0.001858 | 0.957001 | 0.926637 | 0.971275 | 0.960846 | 0.990881 | 0.998142 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 2 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 2 | 20 |
BTUMQA225K_307ae105f731dc | train | 0 | 52 | 00000_052 | 52 | Should edema and necrotic or non-enhancing tumor core be treated as an ambiguous pair in this slice? | distinct | classification | ambiguous_subregion_pair | ambiguous_subregion_pair_template_01 | ambiguous_subregion_pair_paraphrase_01 | btumqa_225k | ambiguity_sensitive | easy | no | edema | ncr_net | wide_gap | ambiguous_subregion_pair_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 81 | 62 | 396 | 539 | 1,096 | 13,953 | 0.033497 | 0.062273 | 0.014663 | 0.02297 | 0.010359 | 0.001764 | 0.966503 | 0.937727 | 0.985337 | 0.97703 | 0.989641 | 0.998236 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 3 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 3 | 20 |
BTUMQA225K_37df8b26068573 | train | 0 | 52 | 00000_052 | 52 | Is the reliability difference between enhancing tumor and the peritumoral context region close, moderate, or wide? | moderate_gap | classification | reliability_gap_bucket | reliability_gap_bucket_template_02 | reliability_gap_bucket_paraphrase_02 | btumqa_225k | bucketed | medium | no | enhancing | context | moderate_gap | reliability_gap_bucket_v1 | phase2c_weight | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 81 | 62 | 396 | 539 | 1,096 | 13,953 | 0.033497 | 0.062273 | 0.014663 | 0.02297 | 0.010359 | 0.001764 | 0.966503 | 0.937727 | 0.985337 | 0.97703 | 0.989641 | 0.998236 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 3 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 3 | 20 |
BTUMQA225K_87165d0f2b110d | train | 0 | 52 | 00000_052 | 52 | How large is the uncertainty gap between enhancing tumor and the peritumoral context region? | moderate_gap | classification | uncertainty_gap_bucket | uncertainty_gap_bucket_template_01 | uncertainty_gap_bucket_paraphrase_01 | btumqa_225k | bucketed | medium | no | enhancing | context | moderate_gap | uncertainty_gap_bucket_v1 | phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 81 | 62 | 396 | 539 | 1,096 | 13,953 | 0.033497 | 0.062273 | 0.014663 | 0.02297 | 0.010359 | 0.001764 | 0.966503 | 0.937727 | 0.985337 | 0.97703 | 0.989641 | 0.998236 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 3 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 3 | 20 |
BTUMQA225K_0b60c5304f6152 | train | 0 | 53 | 00000_053 | 53 | What best describes the uncertainty separation between enhancing tumor and the peritumoral context region? | close_gap | classification | uncertainty_gap_bucket | uncertainty_gap_bucket_template_03 | uncertainty_gap_bucket_paraphrase_03 | btumqa_225k | bucketed | hard | yes | enhancing | context | close_gap | uncertainty_gap_bucket_v1 | phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 107 | 54 | 542 | 703 | 1,314 | 14,200 | 0.035751 | 0.0524 | 0.012709 | 0.019265 | 0.012336 | 0.002166 | 0.964249 | 0.9476 | 0.987291 | 0.980735 | 0.987664 | 0.997834 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 4 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 4 | 20 |
BTUMQA225K_390b449db9c0c3 | train | 0 | 53 | 00000_053 | 53 | What is the confidence-qualified extent of the whole tumor in this slice? | small_uncertain | classification | confidence_qualified_extent | confidence_qualified_extent_template_01 | confidence_qualified_extent_paraphrase_01 | btumqa_225k | confidence_qualified | hard | no | tumor | null | moderate_gap | confidence_qualified_extent_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 107 | 54 | 542 | 703 | 1,314 | 14,200 | 0.035751 | 0.0524 | 0.012709 | 0.019265 | 0.012336 | 0.002166 | 0.964249 | 0.9476 | 0.987291 | 0.980735 | 0.987664 | 0.997834 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 4 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 4 | 20 |
BTUMQA225K_a5ce32851b048e | train | 0 | 53 | 00000_053 | 53 | Between enhancing tumor and the peritumoral context region, which token is more reliable? | context | classification | more_reliable_region | more_reliable_region_template_03 | more_reliable_region_paraphrase_03 | btumqa_225k | comparative | hard | yes | enhancing | context | close_gap | more_reliable_region_v1 | phase2c_weight | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 107 | 54 | 542 | 703 | 1,314 | 14,200 | 0.035751 | 0.0524 | 0.012709 | 0.019265 | 0.012336 | 0.002166 | 0.964249 | 0.9476 | 0.987291 | 0.980735 | 0.987664 | 0.997834 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 4 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 4 | 20 |
BTUMQA225K_5a9e04b4aa656c | train | 0 | 54 | 00000_054 | 54 | Which region is the riskiest evidence source in this MRI slice? | ncr_net | classification | highest_risk_region | highest_risk_region_template_03 | highest_risk_region_paraphrase_03 | btumqa_225k | ranking | medium | no | ncr_net | edema | moderate_gap | highest_risk_region_v1 | phase2a_area+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 137 | 89 | 653 | 879 | 1,408 | 14,494 | 0.0351 | 0.046778 | 0.011802 | 0.018975 | 0.013052 | 0.002502 | 0.9649 | 0.953222 | 0.988198 | 0.981025 | 0.986948 | 0.997498 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 5 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 5 | 20 |
BTUMQA225K_63a891f4fb13fb | train | 0 | 54 | 00000_054 | 54 | Is necrotic or non-enhancing tumor core confidently present, uncertainly present, or not present here? | uncertain_present | classification | confidence_qualified_presence | confidence_qualified_presence_template_02 | confidence_qualified_presence_paraphrase_02 | btumqa_225k | confidence_qualified | hard | no | ncr_net | null | moderate_gap | confidence_qualified_presence_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 137 | 89 | 653 | 879 | 1,408 | 14,494 | 0.0351 | 0.046778 | 0.011802 | 0.018975 | 0.013052 | 0.002502 | 0.9649 | 0.953222 | 0.988198 | 0.981025 | 0.986948 | 0.997498 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 5 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 5 | 20 |
BTUMQA225K_ad74ae6f9c9d4b | train | 0 | 54 | 00000_054 | 54 | Which region should be trusted more here: the whole tumor region or the peritumoral context region? | context | classification | more_reliable_region | more_reliable_region_template_02 | more_reliable_region_paraphrase_02 | btumqa_225k | comparative | medium | no | tumor | context | moderate_gap | more_reliable_region_v1 | phase2c_weight | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 137 | 89 | 653 | 879 | 1,408 | 14,494 | 0.0351 | 0.046778 | 0.011802 | 0.018975 | 0.013052 | 0.002502 | 0.9649 | 0.953222 | 0.988198 | 0.981025 | 0.986948 | 0.997498 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 5 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 5 | 20 |
BTUMQA225K_bb8fde545885bd | train | 0 | 54 | 00000_054 | 54 | Does reliability-aware interpretation preserve the raw dominant tumor component? | consistent | classification | uncertainty_consistency_check | uncertainty_consistency_check_template_03 | uncertainty_consistency_check_paraphrase_03 | btumqa_225k | ambiguity_sensitive | medium | no | enhancing | enhancing | moderate_gap | uncertainty_consistency_check_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 137 | 89 | 653 | 879 | 1,408 | 14,494 | 0.0351 | 0.046778 | 0.011802 | 0.018975 | 0.013052 | 0.002502 | 0.9649 | 0.953222 | 0.988198 | 0.981025 | 0.986948 | 0.997498 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 5 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 5 | 20 |
BTUMQA225K_d584392101e70a | train | 0 | 54 | 00000_054 | 54 | Are edema and necrotic or non-enhancing tumor core too close to separate confidently here? | distinct | classification | ambiguous_subregion_pair | ambiguous_subregion_pair_template_02 | ambiguous_subregion_pair_paraphrase_02 | btumqa_225k | ambiguity_sensitive | easy | no | edema | ncr_net | wide_gap | ambiguous_subregion_pair_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 137 | 89 | 653 | 879 | 1,408 | 14,494 | 0.0351 | 0.046778 | 0.011802 | 0.018975 | 0.013052 | 0.002502 | 0.9649 | 0.953222 | 0.988198 | 0.981025 | 0.986948 | 0.997498 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 5 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 5 | 20 |
BTUMQA225K_ec951c8b78d4a4 | train | 0 | 54 | 00000_054 | 54 | Which tumor subregion is strongest after uncertainty-aware adjustment? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_02 | dominant_region_under_uncertainty_paraphrase_02 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | edema | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 137 | 89 | 653 | 879 | 1,408 | 14,494 | 0.0351 | 0.046778 | 0.011802 | 0.018975 | 0.013052 | 0.002502 | 0.9649 | 0.953222 | 0.988198 | 0.981025 | 0.986948 | 0.997498 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 5 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 5 | 20 |
BTUMQA225K_0542cee8bbfa4d | train | 0 | 55 | 00000_055 | 55 | How large is the uncertainty gap between edema and necrotic or non-enhancing tumor core? | close_gap | classification | uncertainty_gap_bucket | uncertainty_gap_bucket_template_01 | uncertainty_gap_bucket_paraphrase_01 | btumqa_225k | bucketed | hard | yes | edema | ncr_net | close_gap | uncertainty_gap_bucket_v1 | phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 165 | 116 | 745 | 1,026 | 1,483 | 14,774 | 0.037249 | 0.037247 | 0.011717 | 0.01871 | 0.013199 | 0.002751 | 0.962751 | 0.962753 | 0.988283 | 0.98129 | 0.986801 | 0.997249 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 6 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 6 | 20 |
BTUMQA225K_bba5d3fef8cfa4 | train | 0 | 55 | 00000_055 | 55 | Between edema and necrotic or non-enhancing tumor core, which region is more reliable for reasoning? | ncr_net | classification | more_reliable_region | more_reliable_region_template_01 | more_reliable_region_paraphrase_01 | btumqa_225k | comparative | hard | yes | edema | ncr_net | close_gap | more_reliable_region_v1 | phase2c_weight | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 165 | 116 | 745 | 1,026 | 1,483 | 14,774 | 0.037249 | 0.037247 | 0.011717 | 0.01871 | 0.013199 | 0.002751 | 0.962751 | 0.962753 | 0.988283 | 0.98129 | 0.986801 | 0.997249 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 6 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 6 | 20 |
BTUMQA225K_f5f773e281f6ee | train | 0 | 55 | 00000_055 | 55 | Which visual region carries the highest reasoning risk in this slice? | edema | classification | highest_risk_region | highest_risk_region_template_01 | highest_risk_region_paraphrase_01 | btumqa_225k | ranking | hard | yes | edema | ncr_net | close_gap | highest_risk_region_v1 | phase2a_area+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 165 | 116 | 745 | 1,026 | 1,483 | 14,774 | 0.037249 | 0.037247 | 0.011717 | 0.01871 | 0.013199 | 0.002751 | 0.962751 | 0.962753 | 0.988283 | 0.98129 | 0.986801 | 0.997249 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 6 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 6 | 20 |
BTUMQA225K_80e8a73e6d33b0 | train | 0 | 56 | 00000_056 | 56 | Which visual region carries the highest reasoning risk in this slice? | edema | classification | highest_risk_region | highest_risk_region_template_01 | highest_risk_region_paraphrase_01 | btumqa_225k | ranking | easy | no | edema | ncr_net | wide_gap | highest_risk_region_v1 | phase2a_area+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 167 | 167 | 828 | 1,162 | 1,528 | 15,037 | 0.03772 | 0.02223 | 0.011537 | 0.016837 | 0.011456 | 0.002621 | 0.96228 | 0.977771 | 0.988463 | 0.983163 | 0.988544 | 0.997379 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 7 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 7 | 20 |
BTUMQA225K_a700c2d97bfb8f | train | 0 | 56 | 00000_056 | 56 | After accounting for reliability, which tumor subregion remains most dominant in this slice? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_01 | dominant_region_under_uncertainty_paraphrase_01 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | ncr_net | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 167 | 167 | 828 | 1,162 | 1,528 | 15,037 | 0.03772 | 0.02223 | 0.011537 | 0.016837 | 0.011456 | 0.002621 | 0.96228 | 0.977771 | 0.988463 | 0.983163 | 0.988544 | 0.997379 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 7 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 7 | 20 |
BTUMQA225K_b5c358516c69f3 | train | 0 | 56 | 00000_056 | 56 | Should edema and necrotic or non-enhancing tumor core be treated as an ambiguous pair in this slice? | distinct | classification | ambiguous_subregion_pair | ambiguous_subregion_pair_template_01 | ambiguous_subregion_pair_paraphrase_01 | btumqa_225k | ambiguity_sensitive | medium | no | edema | ncr_net | moderate_gap | ambiguous_subregion_pair_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 167 | 167 | 828 | 1,162 | 1,528 | 15,037 | 0.03772 | 0.02223 | 0.011537 | 0.016837 | 0.011456 | 0.002621 | 0.96228 | 0.977771 | 0.988463 | 0.983163 | 0.988544 | 0.997379 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 7 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 7 | 20 |
BTUMQA225K_daf9e1cb724d83 | train | 0 | 56 | 00000_056 | 56 | Between enhancing tumor and the whole tumor region, which token is more reliable? | enhancing | classification | more_reliable_region | more_reliable_region_template_03 | more_reliable_region_paraphrase_03 | btumqa_225k | comparative | medium | no | enhancing | tumor | moderate_gap | more_reliable_region_v1 | phase2c_weight | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 167 | 167 | 828 | 1,162 | 1,528 | 15,037 | 0.03772 | 0.02223 | 0.011537 | 0.016837 | 0.011456 | 0.002621 | 0.96228 | 0.977771 | 0.988463 | 0.983163 | 0.988544 | 0.997379 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 7 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 7 | 20 |
BTUMQA225K_db93225a706595 | train | 0 | 56 | 00000_056 | 56 | Which region is safest to trust for reasoning in this slice? | context | classification | safe_region_for_reasoning | safe_region_for_reasoning_template_01 | safe_region_for_reasoning_paraphrase_01 | btumqa_225k | ranking | hard | yes | context | tumor | close_gap | safe_region_for_reasoning_v1 | phase2a_area+phase2c_weight | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 167 | 167 | 828 | 1,162 | 1,528 | 15,037 | 0.03772 | 0.02223 | 0.011537 | 0.016837 | 0.011456 | 0.002621 | 0.96228 | 0.977771 | 0.988463 | 0.983163 | 0.988544 | 0.997379 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 7 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 7 | 20 |
BTUMQA225K_06e1de598c7c44 | train | 0 | 57 | 00000_057 | 57 | Is edema confidently present, uncertainly present, or not present here? | uncertain_present | classification | confidence_qualified_presence | confidence_qualified_presence_template_02 | confidence_qualified_presence_paraphrase_02 | btumqa_225k | confidence_qualified | hard | no | edema | null | moderate_gap | confidence_qualified_presence_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 141 | 188 | 938 | 1,267 | 1,760 | 15,351 | 0.034985 | 0.014566 | 0.008931 | 0.012667 | 0.009844 | 0.002322 | 0.965015 | 0.985434 | 0.991069 | 0.987333 | 0.990156 | 0.997678 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 8 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 8 | 20 |
BTUMQA225K_7f484219b7a866 | train | 0 | 57 | 00000_057 | 57 | How large is the uncertainty gap between enhancing tumor and the peritumoral context region? | close_gap | classification | uncertainty_gap_bucket | uncertainty_gap_bucket_template_01 | uncertainty_gap_bucket_paraphrase_01 | btumqa_225k | bucketed | hard | yes | enhancing | context | close_gap | uncertainty_gap_bucket_v1 | phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 141 | 188 | 938 | 1,267 | 1,760 | 15,351 | 0.034985 | 0.014566 | 0.008931 | 0.012667 | 0.009844 | 0.002322 | 0.965015 | 0.985434 | 0.991069 | 0.987333 | 0.990156 | 0.997678 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 8 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 8 | 20 |
BTUMQA225K_90059085ac8e55 | train | 0 | 57 | 00000_057 | 57 | Which region is least risky to inspect in this slice? | enhancing | classification | lowest_risk_region | lowest_risk_region_template_02 | lowest_risk_region_paraphrase_02 | btumqa_225k | ranking | medium | no | enhancing | context | moderate_gap | lowest_risk_region_v1 | phase2a_area+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 141 | 188 | 938 | 1,267 | 1,760 | 15,351 | 0.034985 | 0.014566 | 0.008931 | 0.012667 | 0.009844 | 0.002322 | 0.965015 | 0.985434 | 0.991069 | 0.987333 | 0.990156 | 0.997678 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 8 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 8 | 20 |
BTUMQA225K_b07bbb7e8cd396 | train | 0 | 57 | 00000_057 | 57 | Between enhancing tumor and the peritumoral context region, which region is more reliable for reasoning? | enhancing | classification | more_reliable_region | more_reliable_region_template_01 | more_reliable_region_paraphrase_01 | btumqa_225k | comparative | hard | yes | enhancing | context | close_gap | more_reliable_region_v1 | phase2c_weight | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 141 | 188 | 938 | 1,267 | 1,760 | 15,351 | 0.034985 | 0.014566 | 0.008931 | 0.012667 | 0.009844 | 0.002322 | 0.965015 | 0.985434 | 0.991069 | 0.987333 | 0.990156 | 0.997678 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 8 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 8 | 20 |
BTUMQA225K_b16b2e0dc2f13d | train | 0 | 57 | 00000_057 | 57 | Is necrotic or non-enhancing tumor core confidently present, uncertainly present, or not present here? | confident_present | classification | confidence_qualified_presence | confidence_qualified_presence_template_02 | confidence_qualified_presence_paraphrase_02 | btumqa_225k | confidence_qualified | medium | yes | ncr_net | null | close_gap | confidence_qualified_presence_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 141 | 188 | 938 | 1,267 | 1,760 | 15,351 | 0.034985 | 0.014566 | 0.008931 | 0.012667 | 0.009844 | 0.002322 | 0.965015 | 0.985434 | 0.991069 | 0.987333 | 0.990156 | 0.997678 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 8 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 8 | 20 |
BTUMQA225K_b561ccdd8ff0d6 | train | 0 | 57 | 00000_057 | 57 | Under uncertainty-aware interpretation, which tumor subregion is dominant here? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_03 | dominant_region_under_uncertainty_paraphrase_03 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | ncr_net | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 141 | 188 | 938 | 1,267 | 1,760 | 15,351 | 0.034985 | 0.014566 | 0.008931 | 0.012667 | 0.009844 | 0.002322 | 0.965015 | 0.985434 | 0.991069 | 0.987333 | 0.990156 | 0.997678 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 8 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 8 | 20 |
BTUMQA225K_ec2cc8bb079c1e | train | 0 | 57 | 00000_057 | 57 | Does this slice show an ambiguity-sensitive competition between edema and necrotic or non-enhancing tumor core? | distinct | classification | ambiguous_subregion_pair | ambiguous_subregion_pair_template_03 | ambiguous_subregion_pair_paraphrase_03 | btumqa_225k | ambiguity_sensitive | easy | no | edema | ncr_net | wide_gap | ambiguous_subregion_pair_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 141 | 188 | 938 | 1,267 | 1,760 | 15,351 | 0.034985 | 0.014566 | 0.008931 | 0.012667 | 0.009844 | 0.002322 | 0.965015 | 0.985434 | 0.991069 | 0.987333 | 0.990156 | 0.997678 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 8 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 8 | 20 |
BTUMQA225K_0c329f136531e1 | train | 0 | 58 | 00000_058 | 58 | What is the confidence-qualified presence status of necrotic or non-enhancing tumor core in this slice? | confident_present | classification | confidence_qualified_presence | confidence_qualified_presence_template_01 | confidence_qualified_presence_paraphrase_01 | btumqa_225k | confidence_qualified | medium | yes | ncr_net | null | close_gap | confidence_qualified_presence_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 149 | 241 | 966 | 1,356 | 2,057 | 15,671 | 0.034493 | 0.012992 | 0.006848 | 0.010977 | 0.00888 | 0.002209 | 0.965507 | 0.987008 | 0.993152 | 0.989023 | 0.99112 | 0.997791 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 9 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 9 | 20 |
BTUMQA225K_14199b7e9a978b | train | 0 | 58 | 00000_058 | 58 | After accounting for reliability, which tumor subregion remains most dominant in this slice? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_01 | dominant_region_under_uncertainty_paraphrase_01 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | ncr_net | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 149 | 241 | 966 | 1,356 | 2,057 | 15,671 | 0.034493 | 0.012992 | 0.006848 | 0.010977 | 0.00888 | 0.002209 | 0.965507 | 0.987008 | 0.993152 | 0.989023 | 0.99112 | 0.997791 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 9 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 9 | 20 |
BTUMQA225K_4440fdbfa3e4a0 | train | 0 | 58 | 00000_058 | 58 | What best describes the reliability separation between necrotic or non-enhancing tumor core and the whole tumor region? | close_gap | classification | reliability_gap_bucket | reliability_gap_bucket_template_03 | reliability_gap_bucket_paraphrase_03 | btumqa_225k | bucketed | hard | yes | ncr_net | tumor | close_gap | reliability_gap_bucket_v1 | phase2c_weight | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 149 | 241 | 966 | 1,356 | 2,057 | 15,671 | 0.034493 | 0.012992 | 0.006848 | 0.010977 | 0.00888 | 0.002209 | 0.965507 | 0.987008 | 0.993152 | 0.989023 | 0.99112 | 0.997791 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 9 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 9 | 20 |
BTUMQA225K_83b34a3c99efc0 | train | 0 | 58 | 00000_058 | 58 | Are edema and necrotic or non-enhancing tumor core too close to separate confidently here? | distinct | classification | ambiguous_subregion_pair | ambiguous_subregion_pair_template_02 | ambiguous_subregion_pair_paraphrase_02 | btumqa_225k | ambiguity_sensitive | easy | no | edema | ncr_net | wide_gap | ambiguous_subregion_pair_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 149 | 241 | 966 | 1,356 | 2,057 | 15,671 | 0.034493 | 0.012992 | 0.006848 | 0.010977 | 0.00888 | 0.002209 | 0.965507 | 0.987008 | 0.993152 | 0.989023 | 0.99112 | 0.997791 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 9 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 9 | 20 |
BTUMQA225K_89f6c78f463758 | train | 0 | 58 | 00000_058 | 58 | What is the confidence-qualified presence status of edema in this slice? | uncertain_present | classification | confidence_qualified_presence | confidence_qualified_presence_template_01 | confidence_qualified_presence_paraphrase_01 | btumqa_225k | confidence_qualified | hard | no | edema | null | moderate_gap | confidence_qualified_presence_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 149 | 241 | 966 | 1,356 | 2,057 | 15,671 | 0.034493 | 0.012992 | 0.006848 | 0.010977 | 0.00888 | 0.002209 | 0.965507 | 0.987008 | 0.993152 | 0.989023 | 0.99112 | 0.997791 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 9 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 9 | 20 |
BTUMQA225K_96421c016ac8eb | train | 0 | 59 | 00000_059 | 59 | Is the uncertainty difference between necrotic or non-enhancing tumor core and the peritumoral context region close, moderate, or wide? | close_gap | classification | uncertainty_gap_bucket | uncertainty_gap_bucket_template_02 | uncertainty_gap_bucket_paraphrase_02 | btumqa_225k | bucketed | hard | yes | ncr_net | context | close_gap | uncertainty_gap_bucket_v1 | phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 169 | 303 | 956 | 1,428 | 2,347 | 15,996 | 0.032122 | 0.008711 | 0.006566 | 0.010046 | 0.008019 | 0.002242 | 0.967878 | 0.991289 | 0.993434 | 0.989954 | 0.991981 | 0.997758 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 10 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 10 | 20 |
BTUMQA225K_9bfc09c88f6e2e | train | 0 | 59 | 00000_059 | 59 | What is the confidence-qualified extent of the whole tumor in this slice? | moderate_confident | classification | confidence_qualified_extent | confidence_qualified_extent_template_01 | confidence_qualified_extent_paraphrase_01 | btumqa_225k | confidence_qualified | medium | yes | tumor | null | close_gap | confidence_qualified_extent_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 169 | 303 | 956 | 1,428 | 2,347 | 15,996 | 0.032122 | 0.008711 | 0.006566 | 0.010046 | 0.008019 | 0.002242 | 0.967878 | 0.991289 | 0.993434 | 0.989954 | 0.991981 | 0.997758 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 10 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 10 | 20 |
BTUMQA225K_c456e6a3d6c298 | train | 0 | 59 | 00000_059 | 59 | Which tumor subregion is strongest after uncertainty-aware adjustment? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_02 | dominant_region_under_uncertainty_paraphrase_02 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | ncr_net | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 169 | 303 | 956 | 1,428 | 2,347 | 15,996 | 0.032122 | 0.008711 | 0.006566 | 0.010046 | 0.008019 | 0.002242 | 0.967878 | 0.991289 | 0.993434 | 0.989954 | 0.991981 | 0.997758 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 10 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 10 | 20 |
BTUMQA225K_e59ddc441d41c9 | train | 0 | 59 | 00000_059 | 59 | Which region should be trusted more here: necrotic or non-enhancing tumor core or the peritumoral context region? | context | classification | more_reliable_region | more_reliable_region_template_02 | more_reliable_region_paraphrase_02 | btumqa_225k | comparative | hard | yes | ncr_net | context | close_gap | more_reliable_region_v1 | phase2c_weight | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 169 | 303 | 956 | 1,428 | 2,347 | 15,996 | 0.032122 | 0.008711 | 0.006566 | 0.010046 | 0.008019 | 0.002242 | 0.967878 | 0.991289 | 0.993434 | 0.989954 | 0.991981 | 0.997758 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 10 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 10 | 20 |
BTUMQA225K_e724c36cbeeeb4 | train | 0 | 59 | 00000_059 | 59 | Between necrotic or non-enhancing tumor core and the whole tumor region, where is the uncertainty higher? | tumor | classification | more_uncertain_region | more_uncertain_region_template_03 | more_uncertain_region_paraphrase_03 | btumqa_225k | comparative | hard | yes | ncr_net | tumor | close_gap | more_uncertain_region_v1 | phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 169 | 303 | 956 | 1,428 | 2,347 | 15,996 | 0.032122 | 0.008711 | 0.006566 | 0.010046 | 0.008019 | 0.002242 | 0.967878 | 0.991289 | 0.993434 | 0.989954 | 0.991981 | 0.997758 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 10 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 10 | 20 |
BTUMQA225K_0f3ae0ea118cb0 | train | 0 | 60 | 00000_060 | 60 | Under uncertainty-aware interpretation, which tumor subregion is dominant here? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_03 | dominant_region_under_uncertainty_paraphrase_03 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | ncr_net | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 207 | 341 | 945 | 1,493 | 2,092 | 16,277 | 0.030391 | 0.00592 | 0.005396 | 0.008981 | 0.007743 | 0.002148 | 0.969609 | 0.99408 | 0.994604 | 0.991019 | 0.992257 | 0.997852 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 11 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 11 | 20 |
BTUMQA225K_22a99d381b0ed7 | train | 0 | 60 | 00000_060 | 60 | Which region is least risky to inspect in this slice? | ncr_net | classification | lowest_risk_region | lowest_risk_region_template_02 | lowest_risk_region_paraphrase_02 | btumqa_225k | ranking | hard | yes | ncr_net | enhancing | close_gap | lowest_risk_region_v1 | phase2a_area+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 207 | 341 | 945 | 1,493 | 2,092 | 16,277 | 0.030391 | 0.00592 | 0.005396 | 0.008981 | 0.007743 | 0.002148 | 0.969609 | 0.99408 | 0.994604 | 0.991019 | 0.992257 | 0.997852 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 11 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 11 | 20 |
BTUMQA225K_2b2a43cdcb247f | train | 0 | 60 | 00000_060 | 60 | Which confidence-qualified extent label best fits the tumor region here? | moderate_confident | classification | confidence_qualified_extent | confidence_qualified_extent_template_03 | confidence_qualified_extent_paraphrase_03 | btumqa_225k | confidence_qualified | medium | yes | tumor | null | close_gap | confidence_qualified_extent_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 207 | 341 | 945 | 1,493 | 2,092 | 16,277 | 0.030391 | 0.00592 | 0.005396 | 0.008981 | 0.007743 | 0.002148 | 0.969609 | 0.99408 | 0.994604 | 0.991019 | 0.992257 | 0.997852 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 11 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 11 | 20 |
BTUMQA225K_2bd15ecfcd2068 | train | 0 | 60 | 00000_060 | 60 | What is the confidence-qualified presence status of edema in this slice? | uncertain_present | classification | confidence_qualified_presence | confidence_qualified_presence_template_01 | confidence_qualified_presence_paraphrase_01 | btumqa_225k | confidence_qualified | hard | no | edema | null | moderate_gap | confidence_qualified_presence_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 207 | 341 | 945 | 1,493 | 2,092 | 16,277 | 0.030391 | 0.00592 | 0.005396 | 0.008981 | 0.007743 | 0.002148 | 0.969609 | 0.99408 | 0.994604 | 0.991019 | 0.992257 | 0.997852 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 11 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 11 | 20 |
BTUMQA225K_30a563929fa89b | train | 0 | 60 | 00000_060 | 60 | Are edema and necrotic or non-enhancing tumor core too close to separate confidently here? | distinct | classification | ambiguous_subregion_pair | ambiguous_subregion_pair_template_02 | ambiguous_subregion_pair_paraphrase_02 | btumqa_225k | ambiguity_sensitive | easy | no | edema | ncr_net | wide_gap | ambiguous_subregion_pair_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 207 | 341 | 945 | 1,493 | 2,092 | 16,277 | 0.030391 | 0.00592 | 0.005396 | 0.008981 | 0.007743 | 0.002148 | 0.969609 | 0.99408 | 0.994604 | 0.991019 | 0.992257 | 0.997852 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 11 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 11 | 20 |
BTUMQA225K_5f296731da13b4 | train | 0 | 60 | 00000_060 | 60 | Does uncertainty-aware dominance agree with raw area dominance in this slice? | consistent | classification | uncertainty_consistency_check | uncertainty_consistency_check_template_01 | uncertainty_consistency_check_paraphrase_01 | btumqa_225k | ambiguity_sensitive | medium | no | enhancing | enhancing | moderate_gap | uncertainty_consistency_check_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 207 | 341 | 945 | 1,493 | 2,092 | 16,277 | 0.030391 | 0.00592 | 0.005396 | 0.008981 | 0.007743 | 0.002148 | 0.969609 | 0.99408 | 0.994604 | 0.991019 | 0.992257 | 0.997852 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 11 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 11 | 20 |
BTUMQA225K_d9c8a4024f62af | train | 0 | 60 | 00000_060 | 60 | Which visual region carries the highest reasoning risk in this slice? | edema | classification | highest_risk_region | highest_risk_region_template_01 | highest_risk_region_paraphrase_01 | btumqa_225k | ranking | easy | no | edema | tumor | wide_gap | highest_risk_region_v1 | phase2a_area+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 207 | 341 | 945 | 1,493 | 2,092 | 16,277 | 0.030391 | 0.00592 | 0.005396 | 0.008981 | 0.007743 | 0.002148 | 0.969609 | 0.99408 | 0.994604 | 0.991019 | 0.992257 | 0.997852 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 11 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 11 | 20 |
BTUMQA225K_0a3901a6429de5 | train | 0 | 61 | 00000_061 | 61 | Between necrotic or non-enhancing tumor core and enhancing tumor, which region is more reliable for reasoning? | enhancing | classification | more_reliable_region | more_reliable_region_template_01 | more_reliable_region_paraphrase_01 | btumqa_225k | comparative | hard | yes | ncr_net | enhancing | close_gap | more_reliable_region_v1 | phase2c_weight | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 229 | 401 | 946 | 1,576 | 2,354 | 16,520 | 0.026739 | 0.006695 | 0.005718 | 0.009021 | 0.007097 | 0.002158 | 0.973261 | 0.993305 | 0.994282 | 0.990979 | 0.992903 | 0.997842 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 12 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 12 | 20 |
BTUMQA225K_2ca2acd7574e8b | train | 0 | 61 | 00000_061 | 61 | Which visual region carries the lowest reasoning risk in this slice? | enhancing | classification | lowest_risk_region | lowest_risk_region_template_01 | lowest_risk_region_paraphrase_01 | btumqa_225k | ranking | hard | yes | enhancing | ncr_net | close_gap | lowest_risk_region_v1 | phase2a_area+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 229 | 401 | 946 | 1,576 | 2,354 | 16,520 | 0.026739 | 0.006695 | 0.005718 | 0.009021 | 0.007097 | 0.002158 | 0.973261 | 0.993305 | 0.994282 | 0.990979 | 0.992903 | 0.997842 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 12 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 12 | 20 |
BTUMQA225K_3a6c3a24f9dc7d | train | 0 | 61 | 00000_061 | 61 | Is the uncertainty difference between necrotic or non-enhancing tumor core and the peritumoral context region close, moderate, or wide? | close_gap | classification | uncertainty_gap_bucket | uncertainty_gap_bucket_template_02 | uncertainty_gap_bucket_paraphrase_02 | btumqa_225k | bucketed | hard | yes | ncr_net | context | close_gap | uncertainty_gap_bucket_v1 | phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 229 | 401 | 946 | 1,576 | 2,354 | 16,520 | 0.026739 | 0.006695 | 0.005718 | 0.009021 | 0.007097 | 0.002158 | 0.973261 | 0.993305 | 0.994282 | 0.990979 | 0.992903 | 0.997842 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 12 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 12 | 20 |
BTUMQA225K_58d9947f304840 | train | 0 | 61 | 00000_061 | 61 | Which confidence-qualified extent label best fits the tumor region here? | moderate_confident | classification | confidence_qualified_extent | confidence_qualified_extent_template_03 | confidence_qualified_extent_paraphrase_03 | btumqa_225k | confidence_qualified | medium | yes | tumor | null | close_gap | confidence_qualified_extent_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 229 | 401 | 946 | 1,576 | 2,354 | 16,520 | 0.026739 | 0.006695 | 0.005718 | 0.009021 | 0.007097 | 0.002158 | 0.973261 | 0.993305 | 0.994282 | 0.990979 | 0.992903 | 0.997842 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 12 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 12 | 20 |
BTUMQA225K_d8a7afa823c2d9 | train | 0 | 61 | 00000_061 | 61 | Under uncertainty-aware interpretation, which tumor subregion is dominant here? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_03 | dominant_region_under_uncertainty_paraphrase_03 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | ncr_net | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 229 | 401 | 946 | 1,576 | 2,354 | 16,520 | 0.026739 | 0.006695 | 0.005718 | 0.009021 | 0.007097 | 0.002158 | 0.973261 | 0.993305 | 0.994282 | 0.990979 | 0.992903 | 0.997842 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 12 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 12 | 20 |
BTUMQA225K_c35bfd3d8d6c10 | train | 0 | 62 | 00000_062 | 62 | Under uncertainty-aware interpretation, which tumor subregion is dominant here? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_03 | dominant_region_under_uncertainty_paraphrase_03 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | ncr_net | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 313 | 489 | 904 | 1,706 | 2,653 | 16,721 | 0.022111 | 0.005195 | 0.005713 | 0.008573 | 0.007026 | 0.002154 | 0.977889 | 0.994805 | 0.994287 | 0.991427 | 0.992974 | 0.997846 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 13 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 13 | 20 |
BTUMQA225K_52a634821fc95b | train | 0 | 63 | 00000_063 | 63 | Which region has the lowest evidence risk here? | ncr_net | classification | lowest_risk_region | lowest_risk_region_template_03 | lowest_risk_region_paraphrase_03 | btumqa_225k | ranking | medium | no | ncr_net | enhancing | moderate_gap | lowest_risk_region_v1 | phase2a_area+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 453 | 558 | 876 | 1,887 | 2,481 | 16,881 | 0.018964 | 0.004941 | 0.005372 | 0.008507 | 0.007293 | 0.002186 | 0.981036 | 0.995059 | 0.994628 | 0.991493 | 0.992707 | 0.997814 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 14 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 14 | 20 |
BTUMQA225K_8615257e86f5ee | train | 0 | 63 | 00000_063 | 63 | Between necrotic or non-enhancing tumor core and enhancing tumor, where is the uncertainty higher? | enhancing | classification | more_uncertain_region | more_uncertain_region_template_03 | more_uncertain_region_paraphrase_03 | btumqa_225k | comparative | hard | yes | ncr_net | enhancing | close_gap | more_uncertain_region_v1 | phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 453 | 558 | 876 | 1,887 | 2,481 | 16,881 | 0.018964 | 0.004941 | 0.005372 | 0.008507 | 0.007293 | 0.002186 | 0.981036 | 0.995059 | 0.994628 | 0.991493 | 0.992707 | 0.997814 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 14 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 14 | 20 |
BTUMQA225K_9391f78e6020fc | train | 0 | 63 | 00000_063 | 63 | How should the presence of enhancing tumor be described in this slice? | confident_present | classification | confidence_qualified_presence | confidence_qualified_presence_template_03 | confidence_qualified_presence_paraphrase_03 | btumqa_225k | confidence_qualified | medium | yes | enhancing | null | close_gap | confidence_qualified_presence_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 453 | 558 | 876 | 1,887 | 2,481 | 16,881 | 0.018964 | 0.004941 | 0.005372 | 0.008507 | 0.007293 | 0.002186 | 0.981036 | 0.995059 | 0.994628 | 0.991493 | 0.992707 | 0.997814 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 14 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 14 | 20 |
BTUMQA225K_a6e687b795037c | train | 0 | 63 | 00000_063 | 63 | What is the confidence-qualified extent of the whole tumor in this slice? | moderate_confident | classification | confidence_qualified_extent | confidence_qualified_extent_template_01 | confidence_qualified_extent_paraphrase_01 | btumqa_225k | confidence_qualified | medium | yes | tumor | null | close_gap | confidence_qualified_extent_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 453 | 558 | 876 | 1,887 | 2,481 | 16,881 | 0.018964 | 0.004941 | 0.005372 | 0.008507 | 0.007293 | 0.002186 | 0.981036 | 0.995059 | 0.994628 | 0.991493 | 0.992707 | 0.997814 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 14 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 14 | 20 |
BTUMQA225K_ba667a9f079ee2 | train | 0 | 63 | 00000_063 | 63 | Which region should be treated with the most caution for downstream reasoning? | edema | classification | highest_risk_region | highest_risk_region_template_02 | highest_risk_region_paraphrase_02 | btumqa_225k | ranking | easy | no | edema | tumor | wide_gap | highest_risk_region_v1 | phase2a_area+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 453 | 558 | 876 | 1,887 | 2,481 | 16,881 | 0.018964 | 0.004941 | 0.005372 | 0.008507 | 0.007293 | 0.002186 | 0.981036 | 0.995059 | 0.994628 | 0.991493 | 0.992707 | 0.997814 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 14 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 14 | 20 |
BTUMQA225K_e1c4247b273805 | train | 0 | 63 | 00000_063 | 63 | After accounting for reliability, which tumor subregion remains most dominant in this slice? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_01 | dominant_region_under_uncertainty_paraphrase_01 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | ncr_net | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 453 | 558 | 876 | 1,887 | 2,481 | 16,881 | 0.018964 | 0.004941 | 0.005372 | 0.008507 | 0.007293 | 0.002186 | 0.981036 | 0.995059 | 0.994628 | 0.991493 | 0.992707 | 0.997814 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 14 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 14 | 20 |
BTUMQA225K_1db8a60e46614c | train | 0 | 64 | 00000_064 | 64 | Is the uncertainty difference between the whole tumor region and the peritumoral context region close, moderate, or wide? | close_gap | classification | uncertainty_gap_bucket | uncertainty_gap_bucket_template_02 | uncertainty_gap_bucket_paraphrase_02 | btumqa_225k | bucketed | hard | yes | tumor | context | close_gap | uncertainty_gap_bucket_v1 | phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 507 | 556 | 932 | 1,995 | 2,190 | 17,047 | 0.016516 | 0.003459 | 0.005287 | 0.007631 | 0.00815 | 0.002213 | 0.983484 | 0.996541 | 0.994713 | 0.992369 | 0.99185 | 0.997787 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 15 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 15 | 20 |
BTUMQA225K_26178bd7eea4e5 | train | 0 | 64 | 00000_064 | 64 | Which region should receive the highest trust for reasoning? | context | classification | safe_region_for_reasoning | safe_region_for_reasoning_template_03 | safe_region_for_reasoning_paraphrase_03 | btumqa_225k | ranking | hard | yes | context | tumor | close_gap | safe_region_for_reasoning_v1 | phase2a_area+phase2c_weight | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 507 | 556 | 932 | 1,995 | 2,190 | 17,047 | 0.016516 | 0.003459 | 0.005287 | 0.007631 | 0.00815 | 0.002213 | 0.983484 | 0.996541 | 0.994713 | 0.992369 | 0.99185 | 0.997787 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 15 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 15 | 20 |
BTUMQA225K_368fc61ddf3a78 | train | 0 | 64 | 00000_064 | 64 | After accounting for reliability, which tumor subregion remains most dominant in this slice? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_01 | dominant_region_under_uncertainty_paraphrase_01 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | ncr_net | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 507 | 556 | 932 | 1,995 | 2,190 | 17,047 | 0.016516 | 0.003459 | 0.005287 | 0.007631 | 0.00815 | 0.002213 | 0.983484 | 0.996541 | 0.994713 | 0.992369 | 0.99185 | 0.997787 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 15 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 15 | 20 |
BTUMQA225K_5297a222fe71bd | train | 0 | 64 | 00000_064 | 64 | How large is the reliability gap between the whole tumor region and the peritumoral context region? | close_gap | classification | reliability_gap_bucket | reliability_gap_bucket_template_01 | reliability_gap_bucket_paraphrase_01 | btumqa_225k | bucketed | hard | yes | tumor | context | close_gap | reliability_gap_bucket_v1 | phase2c_weight | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 507 | 556 | 932 | 1,995 | 2,190 | 17,047 | 0.016516 | 0.003459 | 0.005287 | 0.007631 | 0.00815 | 0.002213 | 0.983484 | 0.996541 | 0.994713 | 0.992369 | 0.99185 | 0.997787 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 15 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 15 | 20 |
BTUMQA225K_aa49b1ecb40432 | train | 0 | 64 | 00000_064 | 64 | Between the whole tumor region and the peritumoral context region, which region is more uncertain in this slice? | context | classification | more_uncertain_region | more_uncertain_region_template_01 | more_uncertain_region_paraphrase_01 | btumqa_225k | comparative | hard | yes | tumor | context | close_gap | more_uncertain_region_v1 | phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 507 | 556 | 932 | 1,995 | 2,190 | 17,047 | 0.016516 | 0.003459 | 0.005287 | 0.007631 | 0.00815 | 0.002213 | 0.983484 | 0.996541 | 0.994713 | 0.992369 | 0.99185 | 0.997787 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 15 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 15 | 20 |
BTUMQA225K_0b710f1ac92e7e | train | 0 | 65 | 00000_065 | 65 | Which visual region carries the lowest reasoning risk in this slice? | ncr_net | classification | lowest_risk_region | lowest_risk_region_template_01 | lowest_risk_region_paraphrase_01 | btumqa_225k | ranking | medium | no | ncr_net | enhancing | moderate_gap | lowest_risk_region_v1 | phase2a_area+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 538 | 554 | 971 | 2,063 | 2,290 | 17,191 | 0.018 | 0.003349 | 0.004152 | 0.007548 | 0.009454 | 0.002373 | 0.982 | 0.996651 | 0.995848 | 0.992452 | 0.990546 | 0.997627 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 16 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 16 | 20 |
BTUMQA225K_18b904a5eaadc6 | train | 0 | 65 | 00000_065 | 65 | Are edema and necrotic or non-enhancing tumor core too close to separate confidently here? | distinct | classification | ambiguous_subregion_pair | ambiguous_subregion_pair_template_02 | ambiguous_subregion_pair_paraphrase_02 | btumqa_225k | ambiguity_sensitive | medium | no | edema | ncr_net | moderate_gap | ambiguous_subregion_pair_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 538 | 554 | 971 | 2,063 | 2,290 | 17,191 | 0.018 | 0.003349 | 0.004152 | 0.007548 | 0.009454 | 0.002373 | 0.982 | 0.996651 | 0.995848 | 0.992452 | 0.990546 | 0.997627 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 16 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 16 | 20 |
BTUMQA225K_721dcc7bba1bd6 | train | 0 | 65 | 00000_065 | 65 | How should the presence of edema be described in this slice? | uncertain_present | classification | confidence_qualified_presence | confidence_qualified_presence_template_03 | confidence_qualified_presence_paraphrase_03 | btumqa_225k | confidence_qualified | hard | no | edema | null | moderate_gap | confidence_qualified_presence_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 538 | 554 | 971 | 2,063 | 2,290 | 17,191 | 0.018 | 0.003349 | 0.004152 | 0.007548 | 0.009454 | 0.002373 | 0.982 | 0.996651 | 0.995848 | 0.992452 | 0.990546 | 0.997627 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 16 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 16 | 20 |
BTUMQA225K_baa970ca9724c5 | train | 0 | 65 | 00000_065 | 65 | What best describes the reliability separation between necrotic or non-enhancing tumor core and enhancing tumor? | close_gap | classification | reliability_gap_bucket | reliability_gap_bucket_template_03 | reliability_gap_bucket_paraphrase_03 | btumqa_225k | bucketed | hard | yes | ncr_net | enhancing | close_gap | reliability_gap_bucket_v1 | phase2c_weight | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 538 | 554 | 971 | 2,063 | 2,290 | 17,191 | 0.018 | 0.003349 | 0.004152 | 0.007548 | 0.009454 | 0.002373 | 0.982 | 0.996651 | 0.995848 | 0.992452 | 0.990546 | 0.997627 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 16 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 16 | 20 |
BTUMQA225K_e18299b4e6e055 | train | 0 | 65 | 00000_065 | 65 | Which tumor subregion is strongest after uncertainty-aware adjustment? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_02 | dominant_region_under_uncertainty_paraphrase_02 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | ncr_net | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 538 | 554 | 971 | 2,063 | 2,290 | 17,191 | 0.018 | 0.003349 | 0.004152 | 0.007548 | 0.009454 | 0.002373 | 0.982 | 0.996651 | 0.995848 | 0.992452 | 0.990546 | 0.997627 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 16 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 16 | 20 |
BTUMQA225K_f14e881559b593 | train | 0 | 65 | 00000_065 | 65 | Which region should be treated with the most caution for downstream reasoning? | edema | classification | highest_risk_region | highest_risk_region_template_02 | highest_risk_region_paraphrase_02 | btumqa_225k | ranking | easy | no | edema | context | wide_gap | highest_risk_region_v1 | phase2a_area+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 538 | 554 | 971 | 2,063 | 2,290 | 17,191 | 0.018 | 0.003349 | 0.004152 | 0.007548 | 0.009454 | 0.002373 | 0.982 | 0.996651 | 0.995848 | 0.992452 | 0.990546 | 0.997627 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 16 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 16 | 20 |
BTUMQA225K_5cbd13e44b6e2b | train | 0 | 66 | 00000_066 | 66 | Which visual region carries the highest reasoning risk in this slice? | edema | classification | highest_risk_region | highest_risk_region_template_01 | highest_risk_region_paraphrase_01 | btumqa_225k | ranking | easy | no | edema | context | wide_gap | highest_risk_region_v1 | phase2a_area+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 608 | 581 | 966 | 2,155 | 2,536 | 17,330 | 0.01897 | 0.004713 | 0.005103 | 0.00891 | 0.008835 | 0.002565 | 0.98103 | 0.995287 | 0.994897 | 0.99109 | 0.991165 | 0.997435 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 17 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 17 | 20 |
BTUMQA225K_7390a41526fbfc | train | 0 | 66 | 00000_066 | 66 | After accounting for reliability, which tumor subregion remains most dominant in this slice? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_01 | dominant_region_under_uncertainty_paraphrase_01 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | ncr_net | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 608 | 581 | 966 | 2,155 | 2,536 | 17,330 | 0.01897 | 0.004713 | 0.005103 | 0.00891 | 0.008835 | 0.002565 | 0.98103 | 0.995287 | 0.994897 | 0.99109 | 0.991165 | 0.997435 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 17 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 17 | 20 |
BTUMQA225K_99eafb6e754229 | train | 0 | 66 | 00000_066 | 66 | Which visual region carries the lowest reasoning risk in this slice? | ncr_net | classification | lowest_risk_region | lowest_risk_region_template_01 | lowest_risk_region_paraphrase_01 | btumqa_225k | ranking | medium | no | ncr_net | enhancing | moderate_gap | lowest_risk_region_v1 | phase2a_area+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 608 | 581 | 966 | 2,155 | 2,536 | 17,330 | 0.01897 | 0.004713 | 0.005103 | 0.00891 | 0.008835 | 0.002565 | 0.98103 | 0.995287 | 0.994897 | 0.99109 | 0.991165 | 0.997435 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 17 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 17 | 20 |
BTUMQA225K_e141243238373b | train | 0 | 66 | 00000_066 | 66 | Does this slice show an ambiguity-sensitive competition between edema and necrotic or non-enhancing tumor core? | distinct | classification | ambiguous_subregion_pair | ambiguous_subregion_pair_template_03 | ambiguous_subregion_pair_paraphrase_03 | btumqa_225k | ambiguity_sensitive | medium | no | edema | ncr_net | moderate_gap | ambiguous_subregion_pair_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 608 | 581 | 966 | 2,155 | 2,536 | 17,330 | 0.01897 | 0.004713 | 0.005103 | 0.00891 | 0.008835 | 0.002565 | 0.98103 | 0.995287 | 0.994897 | 0.99109 | 0.991165 | 0.997435 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 17 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 17 | 20 |
BTUMQA225K_03eedae0dd1e33 | train | 0 | 67 | 00000_067 | 67 | After accounting for reliability, which tumor subregion remains most dominant in this slice? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_01 | dominant_region_under_uncertainty_paraphrase_01 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | ncr_net | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 684 | 594 | 938 | 2,216 | 2,513 | 17,418 | 0.019826 | 0.004726 | 0.004473 | 0.00928 | 0.009172 | 0.00265 | 0.980174 | 0.995274 | 0.995527 | 0.99072 | 0.990828 | 0.99735 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 18 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 18 | 20 |
BTUMQA225K_10206e8cdcfc21 | train | 0 | 67 | 00000_067 | 67 | Should edema and necrotic or non-enhancing tumor core be treated as an ambiguous pair in this slice? | distinct | classification | ambiguous_subregion_pair | ambiguous_subregion_pair_template_01 | ambiguous_subregion_pair_paraphrase_01 | btumqa_225k | ambiguity_sensitive | medium | no | edema | ncr_net | moderate_gap | ambiguous_subregion_pair_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 684 | 594 | 938 | 2,216 | 2,513 | 17,418 | 0.019826 | 0.004726 | 0.004473 | 0.00928 | 0.009172 | 0.00265 | 0.980174 | 0.995274 | 0.995527 | 0.99072 | 0.990828 | 0.99735 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 18 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 18 | 20 |
BTUMQA225K_2b6484cdfb359b | train | 0 | 67 | 00000_067 | 67 | Which visual region carries the lowest reasoning risk in this slice? | ncr_net | classification | lowest_risk_region | lowest_risk_region_template_01 | lowest_risk_region_paraphrase_01 | btumqa_225k | ranking | hard | yes | ncr_net | enhancing | close_gap | lowest_risk_region_v1 | phase2a_area+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 684 | 594 | 938 | 2,216 | 2,513 | 17,418 | 0.019826 | 0.004726 | 0.004473 | 0.00928 | 0.009172 | 0.00265 | 0.980174 | 0.995274 | 0.995527 | 0.99072 | 0.990828 | 0.99735 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 18 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 18 | 20 |
BTUMQA225K_6bd0ad4b133459 | train | 0 | 67 | 00000_067 | 67 | Which visual region carries the highest reasoning risk in this slice? | edema | classification | highest_risk_region | highest_risk_region_template_01 | highest_risk_region_paraphrase_01 | btumqa_225k | ranking | easy | no | edema | context | wide_gap | highest_risk_region_v1 | phase2a_area+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 684 | 594 | 938 | 2,216 | 2,513 | 17,418 | 0.019826 | 0.004726 | 0.004473 | 0.00928 | 0.009172 | 0.00265 | 0.980174 | 0.995274 | 0.995527 | 0.99072 | 0.990828 | 0.99735 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 18 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 18 | 20 |
BTUMQA225K_16c1ad788351ad | train | 0 | 68 | 00000_068 | 68 | Should edema and necrotic or non-enhancing tumor core be treated as an ambiguous pair in this slice? | ambiguous | classification | ambiguous_subregion_pair | ambiguous_subregion_pair_template_01 | ambiguous_subregion_pair_paraphrase_01 | btumqa_225k | ambiguity_sensitive | hard | yes | edema | ncr_net | close_gap | ambiguous_subregion_pair_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 753 | 578 | 948 | 2,279 | 2,499 | 17,476 | 0.018879 | 0.004603 | 0.004635 | 0.009333 | 0.009944 | 0.002775 | 0.981121 | 0.995397 | 0.995365 | 0.990667 | 0.990056 | 0.997225 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 19 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 19 | 20 |
BTUMQA225K_52a39d3aaf3144 | train | 0 | 68 | 00000_068 | 68 | Under uncertainty-aware interpretation, which tumor subregion is dominant here? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_03 | dominant_region_under_uncertainty_paraphrase_03 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | ncr_net | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 753 | 578 | 948 | 2,279 | 2,499 | 17,476 | 0.018879 | 0.004603 | 0.004635 | 0.009333 | 0.009944 | 0.002775 | 0.981121 | 0.995397 | 0.995365 | 0.990667 | 0.990056 | 0.997225 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 19 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 19 | 20 |
BTUMQA225K_5595bff1dcc651 | train | 0 | 68 | 00000_068 | 68 | Which region has the lowest evidence risk here? | ncr_net | classification | lowest_risk_region | lowest_risk_region_template_03 | lowest_risk_region_paraphrase_03 | btumqa_225k | ranking | hard | yes | ncr_net | enhancing | close_gap | lowest_risk_region_v1 | phase2a_area+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 753 | 578 | 948 | 2,279 | 2,499 | 17,476 | 0.018879 | 0.004603 | 0.004635 | 0.009333 | 0.009944 | 0.002775 | 0.981121 | 0.995397 | 0.995365 | 0.990667 | 0.990056 | 0.997225 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 19 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 19 | 20 |
BTUMQA225K_e7c1163b47f074 | train | 0 | 68 | 00000_068 | 68 | Does reliability-aware interpretation preserve the raw dominant tumor component? | consistent | classification | uncertainty_consistency_check | uncertainty_consistency_check_template_03 | uncertainty_consistency_check_paraphrase_03 | btumqa_225k | ambiguity_sensitive | medium | no | enhancing | enhancing | moderate_gap | uncertainty_consistency_check_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 753 | 578 | 948 | 2,279 | 2,499 | 17,476 | 0.018879 | 0.004603 | 0.004635 | 0.009333 | 0.009944 | 0.002775 | 0.981121 | 0.995397 | 0.995365 | 0.990667 | 0.990056 | 0.997225 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 19 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 19 | 20 |
BTUMQA225K_ea6a904ab4bea9 | train | 0 | 68 | 00000_068 | 68 | Which region should be treated with the most caution for downstream reasoning? | edema | classification | highest_risk_region | highest_risk_region_template_02 | highest_risk_region_paraphrase_02 | btumqa_225k | ranking | easy | no | edema | context | wide_gap | highest_risk_region_v1 | phase2a_area+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 753 | 578 | 948 | 2,279 | 2,499 | 17,476 | 0.018879 | 0.004603 | 0.004635 | 0.009333 | 0.009944 | 0.002775 | 0.981121 | 0.995397 | 0.995365 | 0.990667 | 0.990056 | 0.997225 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 19 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 19 | 20 |
BTUMQA225K_143f1cb022aa0b | train | 0 | 69 | 00000_069 | 69 | Between necrotic or non-enhancing tumor core and enhancing tumor, which region is more uncertain in this slice? | ncr_net | classification | more_uncertain_region | more_uncertain_region_template_01 | more_uncertain_region_paraphrase_01 | btumqa_225k | comparative | hard | yes | ncr_net | enhancing | close_gap | more_uncertain_region_v1 | phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 799 | 572 | 954 | 2,325 | 2,523 | 17,544 | 0.018628 | 0.004721 | 0.004654 | 0.009473 | 0.010842 | 0.002946 | 0.981372 | 0.995279 | 0.995346 | 0.990527 | 0.989158 | 0.997054 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 20 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 20 | 20 |
BTUMQA225K_677b62298c7f69 | train | 0 | 69 | 00000_069 | 69 | Which region has less reliable visual evidence here: the whole tumor region or the peritumoral context region? | context | classification | more_uncertain_region | more_uncertain_region_template_02 | more_uncertain_region_paraphrase_02 | btumqa_225k | comparative | hard | yes | tumor | context | close_gap | more_uncertain_region_v1 | phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 799 | 572 | 954 | 2,325 | 2,523 | 17,544 | 0.018628 | 0.004721 | 0.004654 | 0.009473 | 0.010842 | 0.002946 | 0.981372 | 0.995279 | 0.995346 | 0.990527 | 0.989158 | 0.997054 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 20 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 20 | 20 |
BTUMQA225K_75cc7e34d993e3 | train | 0 | 69 | 00000_069 | 69 | Which region is the riskiest evidence source in this MRI slice? | edema | classification | highest_risk_region | highest_risk_region_template_03 | highest_risk_region_paraphrase_03 | btumqa_225k | ranking | easy | no | edema | context | wide_gap | highest_risk_region_v1 | phase2a_area+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 799 | 572 | 954 | 2,325 | 2,523 | 17,544 | 0.018628 | 0.004721 | 0.004654 | 0.009473 | 0.010842 | 0.002946 | 0.981372 | 0.995279 | 0.995346 | 0.990527 | 0.989158 | 0.997054 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 20 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 20 | 20 |
BTUMQA225K_76953e955324ad | train | 0 | 69 | 00000_069 | 69 | Which region has the lowest evidence risk here? | ncr_net | classification | lowest_risk_region | lowest_risk_region_template_03 | lowest_risk_region_paraphrase_03 | btumqa_225k | ranking | hard | yes | ncr_net | enhancing | close_gap | lowest_risk_region_v1 | phase2a_area+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 799 | 572 | 954 | 2,325 | 2,523 | 17,544 | 0.018628 | 0.004721 | 0.004654 | 0.009473 | 0.010842 | 0.002946 | 0.981372 | 0.995279 | 0.995346 | 0.990527 | 0.989158 | 0.997054 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 20 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 20 | 20 |
BTUMQA225K_8389872aea93ba | train | 0 | 69 | 00000_069 | 69 | Are edema and necrotic or non-enhancing tumor core too close to separate confidently here? | ambiguous | classification | ambiguous_subregion_pair | ambiguous_subregion_pair_template_02 | ambiguous_subregion_pair_paraphrase_02 | btumqa_225k | ambiguity_sensitive | hard | yes | edema | ncr_net | close_gap | ambiguous_subregion_pair_v1 | phase1_pseudo_mask+phase2b_uncertainty | ambiguity_priority | FLAIR|T1|T1ce|T2 | 1 | 799 | 572 | 954 | 2,325 | 2,523 | 17,544 | 0.018628 | 0.004721 | 0.004654 | 0.009473 | 0.010842 | 0.002946 | 0.981372 | 0.995279 | 0.995346 | 0.990527 | 0.989158 | 0.997054 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 20 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 20 | 20 |
BTUMQA225K_b0e8b827d1ed75 | train | 0 | 69 | 00000_069 | 69 | Under uncertainty-aware interpretation, which tumor subregion is dominant here? | enhancing | classification | dominant_region_under_uncertainty | dominant_region_under_uncertainty_template_03 | dominant_region_under_uncertainty_paraphrase_03 | btumqa_225k | ambiguity_sensitive | easy | no | enhancing | edema | wide_gap | dominant_region_under_uncertainty_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 799 | 572 | 954 | 2,325 | 2,523 | 17,544 | 0.018628 | 0.004721 | 0.004654 | 0.009473 | 0.010842 | 0.002946 | 0.981372 | 0.995279 | 0.995346 | 0.990527 | 0.989158 | 0.997054 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 20 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 20 | 20 |
BTUMQA225K_1c9e460d2ba32d | train | 0 | 70 | 00000_070 | 70 | Does this slice show an ambiguity-sensitive competition between edema and necrotic or non-enhancing tumor core? | distinct | classification | ambiguous_subregion_pair | ambiguous_subregion_pair_template_03 | ambiguous_subregion_pair_paraphrase_03 | btumqa_225k | ambiguity_sensitive | medium | no | edema | ncr_net | moderate_gap | ambiguous_subregion_pair_v1 | phase1_pseudo_mask+phase2b_uncertainty | balanced_family_sampling | FLAIR|T1|T1ce|T2 | 1 | 879 | 558 | 964 | 2,401 | 2,525 | 17,579 | 0.019536 | 0.003797 | 0.00448 | 0.009833 | 0.011157 | 0.003087 | 0.980464 | 0.996203 | 0.99552 | 0.990167 | 0.988843 | 0.996913 | phase_2/p2a_region_tokens/tokens_by_patient/00000.pt | 21 | phase_2/p2c_ugtm_modulated_tokens/modulated_tokens_by_patient/00000.pt | 21 | 20 |
BTUMQA: Brain Tumor MRI Visual Question Answering Dataset
BTUMQA is a large-scale visual question answering dataset designed for controlled research evaluation of brain tumor MRI scans. It contains 225,000 QA pairs mapped to 2D MRI slices, derived from the RSNA BraTS 2021 dataset.
This is the official dataset repository for the paper: "AUGR-VQA: Question-Adaptive Uncertainty-Guided Regional Reasoning for Reliable Brain Tumor MRI Visual Question Answering".
π Paper Code Repository: shuvomonowar00/AUGR-VQA (Private, publishing soon)
This dataset is a controlled research evaluation resource and is not intended for clinical diagnosis, patient treatment, or deployment in real clinical workflows.
π Benchmark Readiness & Clean Metadata Protocol
BTUMQA has passed rigorous data integrity and split-leakage checks, making it a robust benchmark for medical VQA.
To guarantee scientific rigor, the dataset features a strict "Clean Metadata Protocol" that separates valid model inputs from diagnostic metadata.
π Warning: Shortcut Learning Risks
During our Phase 03C audit, we found that certain diagnostic fields contain high mutual information with the target answer.
Do not use the following fields as inputs to your VQA model during training. Doing so will cause your model to "cheat" via metadata shortcuts rather than learning visual reasoning.
candidate_keep_reason(Cramer's V correlation = 0.79)decision_rule_id(Cramer's V correlation = 0.70)label_provenance(Cramer's V correlation = 0.57)
These fields are provided strictly for post-hoc auditing and error analysis.
Disclaimer: This dataset does not claim to be perfectly bias-free. While the clean protocol drastically reduces direct metadata shortcut risks, residual biases (such as question-template or answer-prior drift) remain measurable and should be actively reported when evaluating models.
Dataset Analytics
(Diagnostic visuals from the Phase 03C Clean Metadata Audit)
π Dataset Structure
The data files are located in the btumqa_225k/ folder:
btumqa_225k_qa_pairs.csv(225,000 pairs - full pool)btumqa_225k_train.csv(157,501 pairs)btumqa_225k_val.csv(33,750 pairs)btumqa_225k_test.csv(33,750 pairs)
Data Fields (Categorized by Protocol)
β Allowed Clean Model Inputs
question: The natural language question regarding the MRI slice.answer: The target ground truth answer.modality_context: Available MRI modalities (e.g.,FLAIR|T1|T1ce|T2).phase2a_token_file: Path to the extracted visual tokens.phase2c_file: Path to the UGTM-modulated tokens.- (Note: Token files are dynamically generated via the official AUGR-VQA code repository)
π‘οΈ Clean Safe Audit Descriptors
qa_id,patient_id,slice_id,unique_id: Unique identifiers.split: Dataset split (train,val,test).difficulty_level: Question difficulty (easy,medium,hard).question_family&question_style: Semantic templates and formatting styles.region_target_primary®ion_target_secondary: Target brain regions referred to.ambiguity_flag&signal_gap_bucket: Ambiguity descriptors.
π Forbidden Audit-Only Fields (Do Not Train)
- Area Statistics:
edema_area_pixels,ncr_net_area_pixels,enhancing_area_pixels,tumor_area_pixels,context_area_pixels,global_area_pixels. - Uncertainty Estimates:
edema_uncertainty,ncr_net_uncertainty,enhancing_uncertainty,tumor_uncertainty,context_uncertainty,global_uncertainty. - Modulation Weights:
edema_weight,ncr_net_weight,enhancing_weight,tumor_weight,context_weight,global_weight. - Pipeline Provenance:
decision_rule_id,label_provenance,candidate_keep_reason,mc_dropout_passes.
π Quick Start
Load the dataset seamlessly using the Hugging Face datasets library:
from datasets import load_dataset
# Load the training split
train_dataset = load_dataset("shuvomonowar00/BTUMQA", data_files="btumqa_225k/btumqa_225k_train.csv")
# Load the validation split
val_dataset = load_dataset("shuvomonowar00/BTUMQA", data_files="btumqa_225k/btumqa_225k_val.csv")
# Load the testing split
test_dataset = load_dataset("shuvomonowar00/BTUMQA", data_files="btumqa_225k/btumqa_225k_test.csv")
- Downloads last month
- 180

